{"id":"https://openalex.org/W4387979714","doi":"https://doi.org/10.1183/13993003.congress-2023.pa2146","title":"Real-Life Adverse Effects of the New Cystic Fibrosis Modulator Therapy","display_name":"Real-Life Adverse Effects of the New Cystic Fibrosis Modulator Therapy","publication_year":2023,"publication_date":"2023-09-09","ids":{"openalex":"https://openalex.org/W4387979714","doi":"https://doi.org/10.1183/13993003.congress-2023.pa2146"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2023.pa2146","doi":"https://doi.org/10.1183/13993003.congress-2023.pa2146","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa2146","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adult CF","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073170501","display_name":"Am\u00e9lia Simas Ribeiro","orcid":"https://orcid.org/0000-0002-5150-8395","observed_orcids":["https://orcid.org/0000-0002-5150-8395"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Am\u00e9lia Simas Ribeiro","raw_affiliation_strings":["Centro Hospitalar Barreiro Montijo, Barreiro, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Hospitalar Barreiro Montijo, Barreiro, Portugal","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019952468","display_name":"Pilar Azevedo","orcid":"https://orcid.org/0000-0001-7609-200X","observed_orcids":["https://orcid.org/0000-0001-7609-200X"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Pilar Azevedo","raw_affiliation_strings":["Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210114390"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036229647","display_name":"Carlos Lopes","orcid":"https://orcid.org/0000-0001-7901-5720","observed_orcids":["https://orcid.org/0000-0001-7901-5720"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Carlos Lopes","raw_affiliation_strings":["Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210114390"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA2146","last_page":"PA2146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/elexacaftor-tezacaftor-ivacaftor","display_name":"elexacaftor/tezacaftor/ivacaftor","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cftr-modulator-therapy","display_name":"CFTR modulator therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8669999837875366},{"id":"https://openalex.org/keywords/neuropsychiatric-side-effects","display_name":"neuropsychiatric adverse effects","score":0.9729999899864197},{"id":"https://openalex.org/keywords/real-world-experience","display_name":"real-world experience","score":0.6240000128746033},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.6179999709129333},{"id":"https://openalex.org/keywords/gastrointestinal-symptoms","display_name":"gastrointestinal symptoms","score":0.6579999923706055},{"id":"https://openalex.org/keywords/liver-function-tests","display_name":"liver function tests","score":0.7450000047683716},{"id":"https://openalex.org/keywords/creatine-kinase","display_name":"creatine kinase","score":0.7879999876022339},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8479999899864197},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2780820931","wikidata":"https://www.wikidata.org/wiki/Q29299","display_name":"Irritability","level":3,"score":0.8850207328796387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.80583655834198},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6168472766876221},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5278682112693787},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.49797654151916504},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.48692381381988525},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4792085587978363},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.47705283761024475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4152665436267853},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.13569733500480652}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2023.pa2146","doi":"https://doi.org/10.1183/13993003.congress-2023.pa2146","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa2146","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adult CF","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411427310","https://openalex.org/W4363646894","https://openalex.org/W4379981365","https://openalex.org/W4379093884","https://openalex.org/W4404122246","https://openalex.org/W4400678855","https://openalex.org/W4319335562","https://openalex.org/W4408303993","https://openalex.org/W7127635239","https://openalex.org/W4388296437"],"abstract_inverted_index":{"Introduction:":[0],"In":[1],"clinical":[2],"trials,":[3],"Elexacaftor/Tezacaftor/Ivacaftor":[4],"(ETI)":[5],"showed":[6],"effectivity":[7],"and":[8,35,120,135,150,164,183,186,203,223],"good":[9],"tolerability.":[10],"However,":[11],"real-life":[12,51],"experience":[13],"suggests":[14],"this":[15],"drug":[16,241],"might":[17],"be":[18],"associated":[19],"with":[20,171,181,191,200,213],"a":[21,50,56,66,198,214,231,249],"wider":[22],"range":[23],"of":[24,59,116,123,234],"adverse":[25],"effects":[26],"(AE)":[27],"than":[28],"previously":[29,215],"thought,":[30],"namely":[31,143],"neuropsychiatric":[32,235],"(NPAE).":[33],"Aims":[34],"Objectives:":[36],"We":[37,54,229],"aimed":[38],"to":[39,74,81],"assess":[40],"the":[41,60],"AE":[42,79],"experienced":[43],"by":[44],"patients":[45],"(pts)":[46],"on":[47,62,78,94,210],"ETI,":[48],"in":[49,178,189,197,248],"setting.":[52],"Methods:":[53],"performed":[55],"retrospective":[57],"study":[58],"pts":[61,91,112,127,207],"ETI":[63,85],"followed":[64],"at":[65],"Portuguese":[67],"Cystic":[68],"Fibrosis":[69],"Centre":[70],"from":[71,220,225],"March":[72],"2021":[73],"January":[75],"2023.":[76],"Data":[77],"up":[80],"one":[82,179,190],"year":[83],"after":[84],"start":[86],"was":[87,169,175,195],"collected.":[88],"Results:":[89],"Forty-five":[90],"were":[92,239,246],"started":[93],"ETI.":[95,211],"Eleven":[96,111],"(24%)":[97],"presented":[98,113,141],"skin":[99],"rash.":[100],"Four":[101],"(9%)":[102],"reported":[103,128],"testicular":[104],"hypersensitivity.":[105],"Fifteen":[106],"(33%)":[107],"had":[108],"gastrointestinal":[109],"symptoms.":[110],"self-limited":[114],"changes":[115,155],"liver":[117],"function":[118],"tests":[119],"6":[121],"(13%)":[122],"creatine":[124],"kinase.":[125],"Two":[126,206],"haemoptysis.":[129],"Five":[130],"(11%)":[131],"developed":[132],"arterial":[133],"hypertension":[134,222],"7":[136],"(16%)":[137],"dyslipidaemia.":[138],"Twenty-four":[139],"(53%)":[140],"NPAE,":[142],"headache":[144],"(36%),":[145],"vision":[146],"(2%),":[147],"hearing":[148],"(2%)":[149],"speech":[151],"disturbances":[152],"(4%),":[153,161],"memory":[154,182],"(9%),":[156],"low":[157,204],"mood":[158],"(13%),":[159],"insomnia":[160],"irritability":[162,202],"(7%)":[163],"anxiety":[165],"(11%).":[166],"One":[167],"patient":[168,180,199],"diagnosed":[170],"bipolar":[172],"disorder.":[173],"Treatment":[174],"permanently":[176],"suspended":[177,188],"concentration":[184],"problems":[185],"temporarily":[187],"persistent":[192,201],"headache.":[193],"Dose":[194],"adjusted":[196],"mood.":[205],"died":[208,219],"while":[209],"One,":[212],"undiagnosed":[216],"Chiari":[217],"malformation,":[218],"intracranial":[221],"another":[224],"aortic":[226],"dissection.":[227],"Conclusions:":[228],"found":[230],"high":[232],"incidence":[233],"AE.":[236],"While":[237],"most":[238],"mild,":[240],"suspension":[242],"or":[243],"dose":[244],"reduction":[245],"required":[247],"few":[250],"cases.":[251]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2023-10-28T00:00:00"}